Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02287233
Title A Study Evaluating ABT-199 in Combination With Low-Dose Cytarabine in Treatment-Naïve Subjects With Acute Myelogenous Leukemia (AML)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: senior
Covered Countries USA | ITA | DEU | AUS

Facility Status City State Zip Country Details
Univ Kansas Med Ctr /ID# 131175 Kansas City Kansas 66160 United States Details
Weill Cornell Medical College /ID# 131170 New York New York 10065 United States Details
University of Pittsburgh MC /ID# 131168 Pittsburgh Pennsylvania 15260 United States Details
Vanderbilt University Medical Center /ID# 131177 Nashville Tennessee 37232-0011 United States Details
Fred Hutchinson Cancer Research Center /ID# 131178 Seattle Washington 98109-1024 United States Details
Calvary Mater Newcastle /ID# 136076 Waratah New South Wales 2298 Australia Details
Alfred Health /ID# 131180 Melbourne Victoria 3004 Australia Details
Universitaetsklinikum Hamburg-Eppendorf (UKE) /ID# 133979 Hamburg 20246 Germany Details
Duplicate_A.O.U. Policlinico S.Orsola-Malpighi /ID# 131183 Bologna Emilia-Romagna 40138 Italy Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field